News 15.03.2023 Schlieren (Zurich), Switzerland, March 15, 2023 – Kuros Biosciences today announces continued robust progress with its results for full year 2022, increasing MagnetOs direct sales by 75% and completing enrollment of the randomized stage of the Phase 2 spine study for Fibrin-PTH, confirming its successful transition into a fully-fledged orthobiologics...
Events, External events
Event date: 12.12.2023
Come and join us for the 12th edition of BioFIT, on December 12th & 13th, 2023 in Marseille and online on December 15th!
With the highest attending rate of TTOs, research institutes and academia together with big pharma, emerging and small biotech, diagnostics companies, pre-seed / seed / Series A investors,...
News 10.03.2023 ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., March 09, 2023 (GLOBE NEWSWIRE) -- Ad hoc announcement pursuant to Art. 53 LR: Molecular Partners AG (SIX: MOLN, NASDAQ: MOLN), a clinical-stage biotech company developing a new class of custom-built proteins known as DARPin therapeutics, today announced its corporate highlights and audited financial results...
News 09.03.2023 Zurich-Schlieren, Switzerland, March 9, 2023. Proteomedix, a Swiss diagnostics company committed to advance prostate cancer care, today announced that new results evaluating Proclarix® in combination with imaging were published in BJU International[1]. The early detection of clinically significant prostate cancer decreases prostate cancer mortality. The use of multiparametric magnetic resonance imaging...
Events, Internal events
Event date: 07.03.2023
7th of March, 16.15-17.00
Auditorium Bio Technopark Schlieren, Wagistrasse 25, 8952 Schlieren
Are you working in biotech and love to hear about exciting science, discuss innovative ideas and learn about struggles and creative solutions? So do we! Engaging discussions and collaborations are invaluable for productive science, innovation and for creating new, disruptive ideas. This...